These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 33011255)

  • 1. Physical stability of amorphous pharmaceutical solids: Nucleation, crystal growth, phase separation and effects of the polymers.
    Shi Q; Li F; Yeh S; Wang Y; Xin J
    Int J Pharm; 2020 Nov; 590():119925. PubMed ID: 33011255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical stability and dissolution behaviors of amorphous pharmaceutical solids: Role of surface and interface effects.
    Shi Q; Moinuddin SM; Wang Y; Ahsan F; Li F
    Int J Pharm; 2022 Sep; 625():122098. PubMed ID: 35961416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refining stability and dissolution rate of amorphous drug formulations.
    Grohganz H; Priemel PA; Löbmann K; Nielsen LH; Laitinen R; Mullertz A; Van den Mooter G; Rades T
    Expert Opin Drug Deliv; 2014 Jun; 11(6):977-89. PubMed ID: 24754747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Examination of Water Vapor Sorption by Multicomponent Crystalline and Amorphous Solids and Its Effects on Their Solid-State Properties.
    Newman A; Zografi G
    J Pharm Sci; 2019 Mar; 108(3):1061-1080. PubMed ID: 30391302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-polymer solubility and miscibility: Stability consideration and practical challenges in amorphous solid dispersion development.
    Qian F; Huang J; Hussain MA
    J Pharm Sci; 2010 Jul; 99(7):2941-7. PubMed ID: 20127825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supersaturation, nucleation, and crystal growth during single- and biphasic dissolution of amorphous solid dispersions: polymer effects and implications for oral bioavailability enhancement of poorly water soluble drugs.
    Sarode AL; Wang P; Obara S; Worthen DR
    Eur J Pharm Biopharm; 2014 Apr; 86(3):351-60. PubMed ID: 24161655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-amorphous Drug Delivery Systems: a Review of Physical Stability, In Vitro and In Vivo Performance.
    Shi Q; Wang Y; Moinuddin SM; Feng X; Ahsan F
    AAPS PharmSciTech; 2022 Sep; 23(7):259. PubMed ID: 36123515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques.
    Meng F; Gala U; Chauhan H
    Drug Dev Ind Pharm; 2015; 41(9):1401-15. PubMed ID: 25853292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of polymer type on bioperformance and physical stability of hot melt extruded formulations of a poorly water soluble drug.
    Mitra A; Li L; Marsac P; Marks B; Liu Z; Brown C
    Int J Pharm; 2016 May; 505(1-2):107-14. PubMed ID: 27012984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of amorphous pharmaceutical solids: crystal growth mechanisms and effect of polymer additives.
    Sun Y; Zhu L; Wu T; Cai T; Gunn EM; Yu L
    AAPS J; 2012 Sep; 14(3):380-8. PubMed ID: 22434258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface Stabilization and Dissolution Rate Improvement of Amorphous Compacts with Thin Polymer Coatings: Can We Have It All?
    Novakovic D; Peltonen L; Isomäki A; Fraser-Miller SJ; Nielsen LH; Laaksonen T; Strachan CJ
    Mol Pharm; 2020 Apr; 17(4):1248-1260. PubMed ID: 32027513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermal Stability of Amorphous Solid Dispersions.
    Jelić D
    Molecules; 2021 Jan; 26(1):. PubMed ID: 33466393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
    Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in Enhancement of Dissolution and Supersaturation of Poorly Water-Soluble Drug in Amorphous Pharmaceutical Solids: A Review.
    Shi Q; Li F; Yeh S; Moinuddin SM; Xin J; Xu J; Chen H; Ling B
    AAPS PharmSciTech; 2021 Dec; 23(1):16. PubMed ID: 34893936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amorphous Solid Dispersions: Role of the Polymer and Its Importance in Physical Stability and In Vitro Performance.
    Shi Q; Chen H; Wang Y; Wang R; Xu J; Zhang C
    Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of polymeric excipients on nucleation and crystal growth kinetics of amorphous fluconazole.
    Zhang J; Liu Z; Wu H; Cai T
    Biomater Sci; 2021 Jun; 9(12):4308-4316. PubMed ID: 33621302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging trends in the stabilization of amorphous drugs.
    Laitinen R; Löbmann K; Strachan CJ; Grohganz H; Rades T
    Int J Pharm; 2013 Aug; 453(1):65-79. PubMed ID: 22569230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation into the Solid-State Properties and Dissolution Profile of Spray-Dried Ternary Amorphous Solid Dispersions: A Rational Step toward the Design and Development of a Multicomponent Amorphous System.
    Baghel S; Cathcart H; O'Reilly NJ
    Mol Pharm; 2018 Sep; 15(9):3796-3812. PubMed ID: 30020788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical profiling and molecular dynamics simulations reveal crystallization effects in amorphous formulations.
    Edueng K; Kabedev A; Ekdahl A; Mahlin D; Baumann J; Mudie D; Bergström CAS
    Int J Pharm; 2022 Feb; 613():121360. PubMed ID: 34896563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced Physical Stability of Amorphous Drug Formulations via Dry Polymer Coating.
    Capece M; Davé R
    J Pharm Sci; 2015 Jun; 104(6):2076-2084. PubMed ID: 25902736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.